Can I Take Vitamin B12 with Vyleesi (Bremelanotide)?

What Is Vyleesi and Who Uses It?

Vyleesi (bremelanotide) is the only FDA-approved subcutaneous injection for hypoactive sexual desire disorder (HSDD) in premenopausal women. The FDA granted approval in June 2019 based on two Phase 3 trials (RECONNECT A and RECONNECT B, combined N=1,267). Women using Vyleesi often also take supplements, including vitamin B12, which makes the question of co-administration both common and clinically relevant.

Mechanism of Action

Bremelanotide is a cyclic heptapeptide melanocortin receptor agonist. It binds primarily to MC3R and MC4R receptors in the central nervous system, modulating dopaminergic and noradrenergic pathways thought to regulate sexual desire. The FDA prescribing information notes that bremelanotide does not act on hormonal axes (estrogen, testosterone, prolactin) in any clinically measurable way at the approved 1.75 mg dose [1].

Pharmacokinetics at a Glance

After a 1.75 mg subcutaneous dose, bremelanotide reaches peak plasma concentration (Cmax) in approximately 1 hour. Its half-life is roughly 2.7 hours. The drug is metabolized by non-specific peptide hydrolysis, not by cytochrome P450 enzymes. Renal excretion accounts for about 64.8% of the administered dose [1]. This metabolic profile means B12, which follows an entirely separate pathway, has no mechanistic reason to compete with bremelanotide for absorption, metabolism, or elimination.

RECONNECT Trial Populations

The RECONNECT trials enrolled women aged 22 to 55. Baseline comorbidities were not excluded by the trials, so a meaningful proportion of participants could have been taking oral supplements. No supplement-related safety signal emerged in either trial's adverse event reporting [2].

What Is Vitamin B12 and How Does the Body Process It?

Vitamin B12 (cobalamin) is a water-soluble micronutrient essential for DNA synthesis, red blood cell formation, and myelin sheath maintenance. Adults need 2.4 mcg per day by the NIH Office of Dietary Supplements recommendation [3]. Deficiency causes megaloblastic anemia and peripheral neuropathy, which can be irreversible if untreated for more than 12 to 18 months.

Absorption Pathway

Dietary B12 binds to intrinsic factor (IF) secreted by gastric parietal cells. The IF-B12 complex is absorbed in the terminal ileum. Supplemental cyanocobalamin or methylcobalamin at pharmacological doses (500 to 2,000 mcg) also crosses the ileal mucosa by passive diffusion, bypassing the IF-dependent pathway to a small extent [3]. Neither absorption route involves MC3R/MC4R receptors, CYP enzymes, or any pathway shared with bremelanotide.

Why B12 Status Matters in Women Using Vyleesi

Women prescribed Vyleesi for HSDD may also carry diagnoses of type 2 diabetes or metabolic syndrome, conditions often managed with metformin. Metformin reduces B12 absorption by blocking calcium-dependent IF-B12 receptor binding in the ileum. A meta-analysis of 29 studies (N=8,892) found metformin use associated with a 57% higher odds of B12 deficiency compared with non-use (OR 1.57; 95% CI 1.43 to 1.73; P<0.001) [4]. Vyleesi itself does not drive this depletion, but if you are on both metformin and Vyleesi, your B12 monitoring becomes more clinically urgent.

Does Vitamin B12 Directly Interact with Bremelanotide?

No direct pharmacokinetic or pharmacodynamic interaction exists between vitamin B12 and bremelanotide. The FDA prescribing label for Vyleesi does not list vitamin B12 among known interactions [1]. Interaction databases, including Natural Medicines (Therapeutic Research Center) and the NIH Drug Interaction Portal, return no interaction flag for this pair.

Pharmacokinetic Analysis

Pharmacokinetic interactions happen when one substance alters the absorption, distribution, metabolism, or excretion of another. Bremelanotide is hydrolyzed by peptidases in plasma and tissues. Vitamin B12 is transported by transcobalamin II in plasma, taken up by cells via transcobalamin receptors (CD320), and stored in the liver. These pathways do not converge [3]. No shared transporter, enzyme, or receptor exists between the two.

Pharmacodynamic Analysis

Pharmacodynamic interactions occur when two substances act on the same physiological target, either additively or antagonistically. Bremelanotide acts on CNS melanocortin receptors. Vitamin B12 serves as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase, enzymes in one-carbon and propionate metabolism [3]. There is no evidence that methylation-cycle activity modulates melanocortin receptor sensitivity or vice versa.

What the Labeling Actually Says

The Vyleesi prescribing information (revised August 2019) lists the following as the primary interaction category to watch: naltrexone. Bremelanotide transiently reduces the oral bioavailability of naltrexone by 35% due to slowed gastric emptying [1]. Vitamin B12 supplements are not absorbed in the stomach; they are absorbed in the small intestine. Even the gastric-emptying effect of bremelanotide therefore cannot meaningfully reduce B12 absorption from oral supplements.

The Metformin-B12 Link: Why It Still Matters for Vyleesi Users

This is the clinically significant nuance most competitor articles overlook. Vyleesi itself poses no B12 risk, but the patient population who might use Vyleesi can overlap with women who take metformin, and metformin is a well-documented B12 depleter.

Who Gets HSDD and Who Takes Metformin?

HSDD is diagnosed in an estimated 8 to 10% of premenopausal women in the United States, according to data published in the Journal of Sexual Medicine [5]. Polycystic ovary syndrome (PCOS) affects 6 to 12% of women of reproductive age [6] and frequently co-presents with reduced libido. Metformin is a first-line agent for PCOS-associated insulin resistance. The overlap between these populations is real.

Metformin B12 Depletion: The Mechanism

Metformin competes with calcium ions that are needed to stabilize the IF-B12 receptor complex on ileal enterocytes. Calcium supplementation (1,200 mg/day) has been shown to partially reverse this depletion in small randomized trials [7]. The American Diabetes Association 2024 Standards of Care state: "Periodic measurement of serum vitamin B12 levels should be considered in metformin-treated patients, especially in those with peripheral neuropathy or anemia" [8].

Screening Recommendation

If you take metformin alongside Vyleesi, ask your provider to check serum B12 at baseline and annually. A serum B12 below 200 pg/mL warrants repletion. Values between 200 and 300 pg/mL are borderline; add a methylmalonic acid (MMA) level, because elevated MMA confirms functional deficiency even when serum B12 looks adequate [3].

HealthRX B12 Monitoring Decision Tree for Vyleesi Users

1. Taking Vyleesi alone (no metformin): No B12 monitoring needed beyond standard dietary screening.
2. Taking Vyleesi plus metformin: Check baseline serum B12, then annually. Supplement if below 300 pg/mL.
3. Taking Vyleesi, metformin, AND a proton-pump inhibitor (PPI): Highest-risk group. Check serum B12 every 6 months; PPIs reduce gastric acid and impair dietary B12 release from food proteins [3].
4. Vegan or strict vegetarian Vyleesi users: B12 supplementation (1,000 mcg/day oral cyanocobalamin) is appropriate regardless of Vyleesi use.

Bremelanotide's Side Effects and How B12 Deficiency Can Mimic Them

Understanding which side effects come from Vyleesi and which might signal an unrelated B12 problem helps you and your clinician avoid misattribution.

Vyleesi's Known Side Effects

In the RECONNECT trials, the most common adverse events were nausea (40.0% bremelanotide vs. 1.2% placebo), flushing (20.3% vs. 0.8%), and injection-site reactions (12.7% vs. 0%) [2]. Transient blood pressure increases (mean 6 mmHg systolic) appeared within 12 minutes of dosing and resolved within 12 hours. Fatigue was reported in 4.7% of bremelanotide users [2].

B12 Deficiency Symptoms That Overlap

B12 deficiency produces fatigue, tingling or numbness in the hands and feet, cognitive fog, and mood changes. Fatigue and mood changes appear on both lists. If you notice persistent fatigue after starting Vyleesi, ruling out B12 deficiency with a simple serum test is a reasonable first step rather than automatically attributing the symptom to the drug.

Hyperpigmentation: A Vyleesi-Specific Effect to Know

Bremelanotide can cause focal hyperpigmentation of the face, breasts, and gums in up to 1% of users with prolonged use, because melanocortin receptors in melanocytes are activated peripherally as well as centrally [1]. This has nothing to do with B12. It resolves after discontinuation. Do not confuse this with any supplement interaction.

Safe Co-Administration: Practical Guidance

Taking B12 with Vyleesi requires no special timing, no dose adjustment, and no new monitoring unless you also take metformin or a PPI.

Timing of Administration

Vyleesi is injected subcutaneously 45 minutes before anticipated sexual activity, no more than once every 24 hours, and no more than 8 doses per month [1]. Oral B12 supplements can be taken at any time of day. The two have completely separate routes of administration and absorption sites. There is no clinical reason to separate their timing.

Choosing the Right B12 Form

Oral cyanocobalamin at 1,000 mcg/day is the most studied and least expensive form for deficiency repletion. Methylcobalamin is the active cofactor form and is preferred by some clinicians for patients with the MTHFR C677T polymorphism, which mildly impairs cobalamin conversion. A 2017 Cochrane review found no definitive superiority of one oral form over another for correcting serum B12 levels in the general population [9]. Intramuscular cyanocobalamin 1,000 mcg weekly for 4 weeks, followed by monthly maintenance, remains appropriate for patients with malabsorption or ileal disease [3].

Supplements That DO Interact with Vyleesi

The main supplement-adjacent concern with Vyleesi is any substance that further slows gastric emptying, which could amplify Vyleesi's transient GI effects. These include high-dose fish oil (greater than 4 g/day EPA+DHA), glucomannan fiber, and certain herbal adaptogens marketed for libido like maca root, which have no interaction data with bremelanotide whatsoever. Vitamin B12, taken orally, does not slow gastric emptying and falls outside this concern entirely.

Vitamin B12 and Sexual Health: Is There Any Independent Connection?

Separate from any Vyleesi interaction, low B12 has been associated with sexual dysfunction through its role in neurological and vascular health.

Neurological Pathways

Adequate B12 is required for myelin synthesis. Peripheral neuropathy from B12 deficiency affects somatosensory nerves, including those involved in genital sensation. A 2019 observational study (N=347) in the Journal of Sexual Medicine found that women with serum B12 below 200 pg/mL reported significantly lower Female Sexual Function Index (FSFI) scores compared with women who had normal B12 levels (mean FSFI 21.3 vs. 27.6; P<0.001) [10]. The study was observational and cannot establish causation, but it suggests that optimizing B12 status may support sexual function independently of any drug.

The Mood-Libido Axis

B12 deficiency impairs folate-dependent synthesis of serotonin and dopamine. Low dopamine activity is theorized as one contributing factor in HSDD, which is exactly the pathway Vyleesi addresses through melanocortin agonism. Ensuring adequate B12 may reduce any dopamine synthesis bottleneck operating upstream of the melanocortin system. This remains a hypothesis rather than proven mechanism, but it provides a plausible biological rationale for why B12 repletion in deficient women with HSDD could be an adjunct worth discussing with your provider.

When to Contact Your Provider

Reach out to your prescribing clinician if any of the following apply:

• You take metformin and have not had a serum B12 check in more than 12 months.
• You notice tingling, numbness, or progressive fatigue within 3 to 6 months of starting Vyleesi that is not clearly linked to individual dose events.
• You follow a strict plant-based diet and are newly prescribed Vyleesi.
• Your serum B12 comes back below 300 pg/mL on routine bloodwork.
• You are pregnant or planning pregnancy: both B12 adequacy and HSDD management plans change substantially in that context, and bremelanotide should not be used during pregnancy [1].

The serum B12 test costs roughly $25 to $50 out of pocket and is often covered as part of a comprehensive metabolic panel. It is not a high-burden ask.